19 C
Los Angeles
August 4, 2025
Business

GSK Pharma Q1 results: PAT rises 12% to ₹279 cr, income declines marginally

Total income declined marginally to ₹849 crore for the first quarter as compared with ₹850 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing

​Total income declined marginally to ₹849 crore for the first quarter as compared with ₹850 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing 

Related posts

Three nipah virus cases reported in Kerala in 2025, 677 contacts were traced: Govt tells LS – ET HealthWorld

News-Soban-Admin

Rolls-Royce still vying to codevelop India’s stealth jet engine: Alex Zino

News-Soban-Admin

Lumen narrows loss, lifts free cash flow forecast on tax savings

News-Soban-Admin

Leave a Comment